Perrigo Omeprazole Delayed Release Tablets 20 mg Drug Facts | Good Sense Omeprazole
Omeprazole delayed-release tablet, 20 mg
Acid reducer
Allergy alert: Do not use if you are allergic to omeprazole
if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate
1-800-719-9260
Omeprazole Delayed Release Tablets 20 mg
Acid Reducer
Please read all of this package insert before taking Omeprazole Delayed Release Tablets 20 mg.
Save this to read, as you need.
How Omeprazole Delayed Release Tablets 20 mg Work For Your Frequent Heartburn
Omeprazole Delayed Release Tablets 20 mg work differently from other heartburn products, such as antacids and other acid reducers. Omeprazole Delayed Release Tablets 20 mg stop acid production at the source - the acid pump that produces stomach acid. Omeprazole Delayed Release Tablets 20 mg are to be used once a day (every 24 hours), every day for 14 days.
What to Expect When Using Omeprazole Delayed Release Tablets 20 mg
Omeprazole Delayed Release Tablets 20 mg are a different type of medicine from antacids and other acid reducers. Omeprazole Delayed Release Tablets 20 mg may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours. Make sure you take the entire 14 days of dosing to treat your frequent heartburn.
Who Should Take Omeprazole Delayed Release Tablets 20 mg
This product is for adults (18 years and older) with frequent heartburn-when you have heartburn 2 or more days a week.
■ Children under 18 years of age: ask a doctor. Heartburn in children may sometimes be caused by a serious condition.
■ Omeprazole Delayed Release Tablets 20 mg are not intended for those who have heartburn infrequently, one episode of heartburn a week or less, or for those who want immediate relief of heartburn.
How to Take Omeprazole Delayed Release Tablets 20 mg
14-Day Course of Treatment
■ Swallow 1 tablet with a glass of water before eating in the morning.
■ Take every day for 14 days.
■ Do not take more than 1 tablet a day.
■ Do not chew or crush the tablets.
■ Do not crush tablets in food.
■ Do not use for more than 14 days unless directed by your doctor.
It is important not to chew or crush these tablets, or crush the tablets in food. This decreases how well Omeprazole Delayed Release Tablets 20 mg work.
When to Take Omeprazole Delayed Release Tablets 20 mg Again
You may repeat a 14-day course of therapy every 4 months.
When to Talk to Your Doctor
Do not take for more than 14 days or more often than every 4 months unless directed by a doctor.
Warnings and When to ask Your Doctor
Allergy alert: Do not use if you are allergic to omeprazole
Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
Ask a doctor before use if you have
■ had heartburn over 3 months. This may be a sign of a more serious condition.
■ heartburn with lightheadedness, sweating or dizziness
■ chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
■ frequent chest pain
■ frequent wheezing, particularly with heartburn
■ unexplained weight loss
■ nausea or vomiting
■ stomach pain
Ask a doctor or pharmacist before use if you are taking
■ warfarin, clopidogrel or cilostazol (blood-thinning medicines)
■ prescription antifungal or anti-yeast medicines
■ diazepam (anxiety medicine)
■ digoxin (heart medicine)
■ tacrolimus (immune system medicine)
■ prescription antiretrovirals (medicines for HIV infection)
Stop use and ask a doctor if
■ your heartburn continues or worsens
■ you need to take this product for more than 14 days
■ you need to take more than 1 course of treatment every 4 months
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Tips for Managing Heartburn
■ Do not lie flat or bend over soon after eating.
■ Do not eat late at night or just before bedtime.
■ Certain foods or drinks are more likely to cause heartburn, such as rich, spicy, fatty and fried foods, chocolate, caffeine, alcohol and even some fruits and vegetables.
■ Eat slowly and do not eat big meals.
■ If you are overweight, lose weight.
■ If you smoke, quit smoking.
■ Raise the head of your bed.
■ Wear loose-fitting clothing around your stomach.
How are Omeprazole Delayed Release Tablets 20 mg Sold
Omeprazole Delayed Release Tablets 20 mg are available in 14 tablet, 28 tablet and 42 tablet sizes. These sizes contain one, two and three 14-day courses of treatment, respectively. Do not use for more than 14 days in a row unless directed by your doctor. For the 28 count (two 14-day courses) and the 42 count (three 14-day courses), you may repeat a 14-day course every 4 months.
For Questions or Comments About Omeprazole Delayed Release Tablets 20 mg
Call 1-800-719-9260
Made in Israel
DISTRIBUTED BY
PERRIGO®
ALLEGAN, MI 49010
Manufactured by:
Dexcel Pharma
Technologies Ltd.
10 Hakidma Street,
Yokneam, 20692, Israel
Treats Frequent Heartburn!
Occurring 2 Or More Days A Week
Omeprazole Delayed Release Tablets 20 mg
Acid Reducer
TreatMyHeartburn.com
# 14-day course{s} of treatment {Replace "#" with actual number of courses of treatment in package}


Manufacturer
L Perrigo Company
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 31st of January 2012
Medications 1208 Associated Medications 
Omeprazole
Omeprazole Delayed Release Tablets, 20 mg
Members mark omeprazole
Sam's West, Inc. Omeprazole Delayed Release Tablets 20 mg Drug Facts
Prilosec otc
Prilosec OTC omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer
Prilosec otc
Prilosec OTC omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer
Omeprazole
Perrigo Omeprazole Delayed Release Tablets 20 mg Drug Facts
Clinical Trials 3073 Associated Clinical Trials 
Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to deter...
Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg
The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole sodium delayed-release 20 mg tablets to Eisai's Aciphex® delayed-release 20 mg tablets following a...
Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)
The purpose of this study is to demonstrate the relative bioavailability of Naproxen delayed-release tablets (375 mg).
Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions
The purpose of this study is to demonstrate the bioequivalence of divalproex sodium 125 MG delayed release tablets.
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
This study will compare the relative bioavailability of 500 mg Divalproex Sodium Delayed-Release Tablets with that of 500 mg Depakote® Tablets following a single oral dose (1 x 500 mg tab...
PubMed Articles 10668 Associated PubMed Articles 
Prolonged Intragastric Drug Delivery Mediated by Eudragit(®) E-Carrageenan Polyelectrolyte Matrix Tablets.
Interpolyelectrolyte (IPE) complexation between carrageenan (CG) and Eudragit E (EE) was studied in 0.1 M HCl and was used to develop floating matrix tablets aimed to prolong gastric-residence time a...
Comparison of pharmacokinetics in beagle dogs of nimesulide bilayer tablets with dispersible tablets.
The purpose of this study was to compare the in vitro release and the in vivo pharmacokinetics of bilayer tablets with the conventional dispersible tablets of nimesulide. The tablets were administered...
Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using pvp-k90 and natural gums.
Conventional dosage form is nowadays mostly replaced by sustained release formulation in order to increase drug efficacy and patient compliance. The sustained release properties of the PVP K90 alone a...
Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets.
Chitosan (CS), a positively charged polysaccharide, and magnesium aluminum silicate (MAS), a negatively charged clay with silicate layers, can electrostatically interact to form nanocomposite films. I...
Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity.
The release of a model drug substance, methylparaben, was studied in matrix tablets composed of hydroxypropyl methylcellulose (HPMC) batches of the USP 2208 grade that had different chemical compositi...